Dr. Pahlajani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1020 W 34th St
Austin, TX 78705Phone+1 512-687-1950Fax+1 512-687-1490
Education & Training
- Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2005 - 2009
- Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 2004 - 2005
- Rutgers Robert Wood Johnson Medical SchoolClass of 2004
Certifications & Licensure
- TX State Medical License 2015 - 2025
- WY State Medical License 2024 - 2025
- FL State Medical License 2012 - 2018
- IA State Medical License 2015 - 2017
- GA State Medical License 2013 - 2014
- NJ State Medical License 2009 - 2013
- PA State Medical License 2004 - 2010
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 15 citationsThe impact of dose‐escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomogramsRadka Stoyanova, N Pahlajani, Brian L. Egleston, Mark K. Buyyounouski, David Y.T. Chen
Cancer. 2013-03-01 - 48 citationsQuantifying rigid and nonrigid motion of liver tumors during stereotactic body radiation therapy.Q. Xu, George Hanna, Jimm Grimm, Gregory J. Kubicek, N Pahlajani
International Journal of Radiation Oncology, Biology, Physics. 2014-09-01 - 51 citationsRadiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer.N Pahlajani, Karen Ruth, Mark K. Buyyounouski, David Y.T. Chen, Eric M. Horwitz
International Journal of Radiation Oncology, Biology, Physics. 2012-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: